174 related articles for article (PubMed ID: 9699182)
1. Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers.
Tsao MS; Liu N; Chen JR; Pappas J; Ho J; To C; Viallet J; Park M; Zhu H
Lung Cancer; 1998 Apr; 20(1):1-16. PubMed ID: 9699182
[TBL] [Abstract][Full Text] [Related]
2. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.
To C; Seiden I; Liu N; Wigle D; Tsao MS
Exp Cell Res; 2002 Feb; 273(1):45-53. PubMed ID: 11795945
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
4. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas.
Olivero M; Rizzo M; Madeddu R; Casadio C; Pennacchietti S; Nicotra MR; Prat M; Maggi G; Arena N; Natali PG; Comoglio PM; Di Renzo MF
Br J Cancer; 1996 Dec; 74(12):1862-8. PubMed ID: 8980383
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
[TBL] [Abstract][Full Text] [Related]
6. Human lung cancer cell line producing hepatocyte growth factor/scatter factor.
Yoshinaga Y; Fujita S; Gotoh M; Nakamura T; Kikuchi M; Hirohashi S
Jpn J Cancer Res; 1992 Dec; 83(12):1257-61. PubMed ID: 1336496
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance.
Ichimura E; Maeshima A; Nakajima T; Nakamura T
Jpn J Cancer Res; 1996 Oct; 87(10):1063-9. PubMed ID: 8957065
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer.
Tsao MS; Yang Y; Marcus A; Liu N; Mou L
Hum Pathol; 2001 Jan; 32(1):57-65. PubMed ID: 11172296
[TBL] [Abstract][Full Text] [Related]
9. Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.
Kanteti R; El-Hashani E; Dhanasingh I; Tretiakova M; Husain AN; Sharma S; Sharma J; Vokes EE; Salgia R
BMC Cancer; 2014 Mar; 14():185. PubMed ID: 24628993
[TBL] [Abstract][Full Text] [Related]
10. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells.
Singh-Kaw P; Zarnegar R; Siegfried JM
Am J Physiol; 1995 Jun; 268(6 Pt 1):L1012-20. PubMed ID: 7611423
[TBL] [Abstract][Full Text] [Related]
11. HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer.
Gumustekin M; Kargi A; Bulut G; Gozukizil A; Ulukus C; Oztop I; Atabey N
Pathol Oncol Res; 2012 Apr; 18(2):209-18. PubMed ID: 21779788
[TBL] [Abstract][Full Text] [Related]
12. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
[TBL] [Abstract][Full Text] [Related]
13. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
14. Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers.
Hiscox SE; Hallett MB; Puntis MC; Nakamura T; Jiang WG
Cancer Invest; 1997; 15(6):513-21. PubMed ID: 9412656
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells.
Chen JT; Lin TS; Chow KC; Huang HH; Chiou SH; Chiang SF; Chen HC; Chuang TL; Lin TY; Chen CY
Am J Respir Cell Mol Biol; 2006 Mar; 34(3):264-73. PubMed ID: 16254251
[TBL] [Abstract][Full Text] [Related]
16. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.
Matsuda Y; Yamamoto T; Kudo M; Kawahara K; Kawamoto M; Nakajima Y; Koizumi K; Nakazawa N; Ishiwata T; Naito Z
Int J Oncol; 2008 Dec; 33(6):1177-85. PubMed ID: 19020750
[TBL] [Abstract][Full Text] [Related]
17. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.
Liu C; Tsao MS
Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369
[TBL] [Abstract][Full Text] [Related]
19. Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung Carcinomas.
Lapère C; Cortot AB; Grégoire V; Cockenpot V; Tulasne D; Copin MC
Am J Surg Pathol; 2017 Mar; 41(3):414-422. PubMed ID: 28098570
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
